Jun 12, 2026 07:01AM
Jun 12, 2026 07:00AM
May 28, 2026 07:00AM
May 7, 2026 04:00PM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Feb 26, 2026 04:00PM Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Feb 23, 2026 07:00AM
Jan 5, 2026 07:00AM
Nov 25, 2025 07:00AM
Nov 6, 2025 04:00PM
Oct 14, 2025 07:00AM
Oct 14, 2025 07:00AM
Oct 10, 2025 04:00PM Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 28, 2025 07:00AM
Aug 20, 2025 07:00AM
Aug 20, 2025 07:00AM
Aug 7, 2025 04:00PM
Jul 24, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 17, 2025 07:00AM Rocket Pharmaceuticals receives FDA RMAT designation for heart gene therapy
Jul 17, 2025 07:00AM
Jun 30, 2025 07:00AM
Jun 30, 2025 07:00AM
May 27, 2025 07:01AM
May 27, 2025 07:00AM
May 15, 2025 03:15PM
May 15, 2025 03:15PM Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy
May 9, 2025 04:30PM
May 8, 2025 04:01PM
Apr 3, 2025 07:00AM
Feb 27, 2025 04:01PM
Jan 2, 2025 04:00PM
Nov 26, 2024 07:00AM
Nov 18, 2024 11:00AM Rocket Pharmaceuticals (RCKT) Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data
Nov 18, 2024 11:00AM
Nov 12, 2024 04:01PM
Nov 8, 2024 07:00AM
Nov 7, 2024 04:01PM
Sep 17, 2024 07:03AM
Sep 17, 2024 07:00AM
Sep 10, 2024 07:03AM Rocket Pharmaceuticals (RCKT) Appoints Mikael Dolsten to its Board
Sep 10, 2024 07:00AM
Aug 27, 2024 07:00AM
Aug 5, 2024 04:01PM
Jun 28, 2024 07:28AM
Jun 28, 2024 07:27AM
May 29, 2024 07:04AM
May 29, 2024 07:00AM Rocket Pharmaceuticals Receives Orphan Medicinal Product Designation from the European Commission for RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
May 10, 2024 06:00AM

1,158,058 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All